glimepiride has been researched along with Stevens-Johnson Syndrome in 1 studies
glimepiride: structure given in first source
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ouni, B | 1 |
| Fathallah, N | 1 |
| Ben-Sayed, N | 1 |
| Abdessayed, N | 1 |
| Slim, R | 1 |
| Sriha, B | 1 |
| Ben Salem, C | 1 |
1 other study available for glimepiride and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Fatal toxic epidermal necrolysis probably related to glimepiride in a patient with a medical history of hypersensitivity to sulfamethoxazole-trimethoprim.
Topics: Humans; Stevens-Johnson Syndrome; Sulfonylurea Compounds; Trimethoprim, Sulfamethoxazole Drug Combin | 2021 |